Burak Dik

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 9

Top Topics

Top Venues

Fundamental & clinical pharmacology

The Journal of pharmacy and pharmacology

Pharmacology research & perspectives

Turkish journal of medical sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Irmak Dik, Burak Dik, Öznur Tufan, Ayşe Er
Evaluation of potential antiviral activities of antimicrobial peptides in fish mucus. Fundamental & clinical pharmacology (2024)
Burak Dik, Hatipoglu Durmus, Mehmet Burak Ates
Potential effects of Resatorvid and alpha lipoic acid on gentamicin-induced nephrotoxicity in rats. Pharmacology research & perspectives 12 (4) (2024)
Burak Dik, Hatipoglu Durmus, Mehmet Burak Ates
Potential effects of Resatorvid and alpha lipoic acid on gentamicin-induced nephrotoxicity in rats. Pharmacology research & perspectives 12 (4) (2024)
Irmak Dik, Burak Dik, Öznur Tufan, Ayşe Er
Evaluation of potential antiviral activities of antimicrobial peptides in fish mucus. Fundamental & clinical pharmacology 38 (4) (2024)
Burak Dik, Tugba Melike Parlak, Mehmet Burak Ates, Öznur Tufan
Exploring the combined therapeutic efficacy of bexarotene and icariin in type 2 diabetic rats. The Journal of pharmacy and pharmacology (2024)
Yasemin Korkmaz, Burak Dik
The comparison of the antidiabetic effects of exenatide, empagliflozin, quercetin, and combination of the drugs in type 2 diabetic rats. Fundamental & clinical pharmacology 38 (3) (2023)
Yasemin Korkmaz, Burak Dik
The comparison of the antidiabetic effects of exenatide, empagliflozin, quercetin, and combination of the drugs in type 2 diabetic rats. Fundamental & clinical pharmacology (2023)
Huseyin Gungor, Mehmet Ekici, Ozhan Karatas, Burak Dik
Protective effect of Allium scorodoprasum L. ethanolic extract in cyclophosphamide-induced hepatotoxicity model in rats. The Journal of pharmacy and pharmacology (2023)
Burak Dik, Devran Coşkun, Emre Bahçivan, Kamil Uney
Potential antidiabetic activity of benzimidazole derivative albendazole and lansoprazole drugs in different doses in experimental type 2 diabetic rats Turkish journal of medical sciences 51 (3) (2021)